RecruitingNot ApplicableNCT07001059
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
Sponsor
Hôpital NOVO
Enrollment
190 participants
Start Date
Sep 4, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Eligibility
Min Age: 50 Years
Inclusion Criteria2
- Patient with suspected GCA
- Patient over 50 years
Exclusion Criteria4
- Patient with history of GCA
- Patient with a history of polymyalgia rheumatic (PMR) without initial PET scan
- Patient with a history of retinal disease, demyelinating disease, or intracranial hypertension
- Use of corticosteroids \> 0.5mg/kg in the last 2 weeks
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTorbital ultrasound
orbital ultrasound at the beginning of the participation, and at 6 months after the inclusion.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07001059
Related Trials
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
NCT071083877 locations
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
NCT068870621 location
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
NCT051933963 locations
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
NCT066096681 location
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
NCT071500001 location